- Josefa Henriquez, Wynand van de Ven, Adrian Melia & Francesco Paolucci (2024). The road to managed competition for mixed public-private health systems: a conceptual framework. Health Economics, Policy and Law. doi: https://doi.org/10.1017/S1744133123000373
- Frederik T. Schut, Frédérique M.E. Franken, Stéphanie A. van der Geest & Marco Varkevisser (2024). Financing COVID-19-related health care costs in the Dutch competitive health system during 2020 and 2021: overall experiences and policy recommendations for improving health system resilience, Health Policy. doi: https://doi.org/10.1016/j.healthpol.2023.104969
- Ghyli Kirshner, Peter Makai, Chiara Brouns, Lonneke Timmers & Ron Kemp (2024), The impact of an ‘evergreening’ strategy nearing patent expiration on the uptake of biosimilars and public healthcare costs: a case study on the introduction of a second administration form of trastuzumab in The Netherlands, European Journal of Health Economics. doi: https://doi.org/10.1007/s10198-023-01648-w
- Nanne van Velzen, Richard Janssen & Marco Varkevisser (2023). Emergency care reconfiguration in the Netherlands: conflicting interests and trade-offs from a multidisciplinary perspective. Health Economics, Policy and Law. doi: https://doi.org/10.1017/S1744133123000099
- Marco Varkevisser, Frédérique Franken, Stéphanie van der Geest & Erik Schut (2023). Competition and collaboration in health care: reconciling the irreconcilable? Lessons from The Netherlands. The European Journal of Health Economics, 24:1019-1021. doi: https://doi.org/10.1007/s10198-023-01619-1
- Wouter van der Schors, Anne-Fleur Roos, Ron Kemp & Marco Varkevisser (2023). Reasons for merging and collaborating in healthcare: Marriage or living apart together? The International Journal of Health Planning and Management, 1-22. doi: https://doi.org/10.1002/hpm.3695
- Erik Schut, Cornelia Henschke & Zeynep Or (2023). Changing roles of health insurers in France, Germany, and the Netherlands: any lessons to learn from Bismarckian systems? Health Economics, Policy and Law. doi: https://doi.org/10.1017/S1744133123000191
- Wouter van der Schors and Marco Varkevisser. Does Enforcement of the Cartel Prohibition in Healthcare Reflect Public and Political Attitudes Towards Competition? A Longitudinal Study From the Netherlands. Journal of Competition Law & Economics, 2023, 00, 1–27. doi: https://doi.org/10.1093/joclec/nhad001
- Aggarwal, A., L. Han, S. van der Geest, D. Lewis, Y. Lievens, J. Borras, et al. Health service planning to assess the expected impact of centralizing specialist cancer services on travel times, equity, and outcomes: a national population-based modelling study. Lancet Oncol. doi: https://doi.org/10.1016/S1470-2045(22)00398-9
- Van der Schors, W., R. Kemp, J. van Hoeve, V. Tjan-Heijnen, J. Maduro, M-J Vrancken Peeters, S. Siesling, M. Varkevisser (2022) Associations of hospital volume and hospital competition with short-term, middle-term and long-term patient outcomes after breast cancer surgery: a retrospective population-based study, BMJ Open. doi:10.1136/bmjopen-2021-057301
- Stolper, K., L. Boonen, F. Schut, M. Varkevisser (2021) Do health insurers use target marketing as a tool for risk selection? Evidence from the Netherlands, Health Policy, https://doi.org/10.1016/j.healthpol.2021.12.005
- Daan Westra, Frederica Angeli, Ron Kemp, Maarten Batterink, Jan Reitsma (2020) If you say so: A mixed-method study of hospital mergers and quality of care, Health Care Management Review.
- W. van der Schors, A-F Roos, R. Kemp & M. Varkevisser (2020) Inter-organizational collaboration between healthcare providers. Health Services Management Research, DOI: 10.1177/0951484820971456
- Stolper, K., L. Boonen, F. Schut, M. Varkevisser (2020) Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition? Health Economics, Policy and Law, forthcoming
- Roos, A-F., O. O'Donnell, F. Schut, E. van Doorslaer, R. van Gestel, M. Varkevisser (2020) Does Price Deregulation in a Competitive Hospital Market Damage Quality? Journal of Health Economics
- W. van der Schors, R. Kemp, M. Varkevisser, Collaboration and Competition Policy in a Market-Based Hospital System: A Case-Study from the Netherlands, Journal of Competition Law and Economics, accepted March 2020
- A. Aggarwal, S. van der Geest, M. Varkevisser, J. van der Meulen, Simulating the impact of centralization of prostate cancer surgery services on travel burden and equity in the English NHS: a national population based model for health service re-design, Cancer Medicine, accepted February 14, 2020
- Moura, A, M. Salm, R. Douven, M. Remmerswaal (2019), Causes of regional variation in Dutch healthcare expenditures: Evidence from movers, Health Economics, https://onlinelibrary.wiley.com/doi/epdf/10.1002/hec.3917
- R. Douven, M. Burger, E. Schut (2019), Does managed competition constrain hospitals’ contract prices? Evidence from the Netherlands, Health Economics, Policy and Law
- KCF Stolper, LHHM Boonen, FT Schut, M Varkevisser (2018), Managed competition in the Netherlands: Do insurers have incentives to steer on quality? Health Policy,
- R. Douven, M. Burger & F.T. Schut (2018). Grote prijsverschillen ziekenhuiszorg, ondanks concurrentie. Economisch-Statistische Berichten, 103 (4762), 276-279.
- F.T. Schut & M. Varkevisser (2017). Competition policy for health care provision in the Netherlands. Health Policy, 121 (2), 126-133. doi: https://doi.org/10.1016/j.healthpol.2016.11.002
- E.M.H. Loozen, M. Varkevisser, F.T. Schut (2014), Dutch Authority for Consumers and Markets fails to meet the standard of proof in recent hospital merger decisions, European Competition Law Review, 35(1): 16-22.
- F.T. Schut & M. Varkevisser (2016). Hebben zorgverzekeraars teveel macht? Nederlands Tijdschrift voor Geneeskunde, 160 (D1133), 1-5.
- A.F. Roos & J.P. Postma (2016). Getting Cold Feet? Why Healthcare Mergers are Abandoned. Health Care Management Review, 41 (2), 155-164. doi: 10.1097/HMR.0000000000000060
- J.P. Postma & A.F. Roos (2016). Why healthcare providers merge. Health Economics, Policy and Law, 11 (02), 121-140. doi: 10.1017/S1744133115000304
- E.M.H. Loozen, M. Varkevisser & F.T. Schut (2016). Goede zorginkoop vergt effectief toezicht op marktmacht. Economisch-Statistische Berichten, 101 (4737), 426-429.
- M. Varkevisser (2015). Aanscherping toezicht ziekenhuisfusies is noodzakelijk. Economisch-Statistische Berichten, 100 (4715), 458-458.
- F.T. Schut & M. Varkevisser (2013). Tackling hospital waiting times: The impact of past and current policies in the Netherlands. Health Policy, 113, 127-133. doi: http://dx.doi.org/10.1016/j.healthpol.2013.05.003
- S.A. van der Geest & M. Varkevisser (2013). Fusies van maatschappen bedreigen zorginkoop. Economisch-Statistische Berichten, 98 (4668), 544-546.